{
    "medicine_id": "fee356a3de5f2e4d6fc60d5b46e094c281ebe0b1",
    "platform_id": "DB16019",
    "metadata": {
        "name": "Adynovi 2000 IU Injection",
        "composition": "2000 IU Gallium Ga 68 gozetotide",
        "clinical_particulars": {
            "therapeutic_indications": "Gallium Ga 68 gozetotide or Gallium Ga 68 PSMA 11 is a radioactive diagnostic agent indicated for positron emission tomography PET of prostate specific membrane antigen PSMA positive lesions in patients with suspected prostate cancer metastasis who are also candidates for initial surgical or radiation therapy It is also indicated for patients with suspected prostate cancer recurrence based on elevated serum prostate specific antigen PSA levels L26981",
            "contraindications": {
                "disease": "There is limited information on the LD sub 50 sub value of Ga 68 PSMA 11 In the event of an overdose it is recommended to enhance drug elimination by hydration frequent bladder voiding or the use of diuretics L26981",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Ga 68 PSMA 11 works by binding to prostate specific membrane antigen PSMA expressed on malignant prostate cancer cells Gallium 68 Ga 68 is a \u03b2 emitting radionuclide and Ga 68 PSMA 11 can be imaged by PET to indicate the presence of PSMA positive prostate cancer lesions in the tissues of the body L26981 Ga 68 PMSA 11 has a high affinity to PSMA and was shown to be effective in imaging of both local prostate cancer tumours and distant metastatic lesions in clinical trials A36121 A225531 In a clinical trial comprising patients with relapsed prostate cancer Ga 68 PSMA 11 PET detection rate was different depending on the clinical stage of biochemical recurrence A225541",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00499",
                        "description": "Flutamide may increase effectiveness of Gallium Ga 68 gozetotide as a diagnostic agent"
                    },
                    {
                        "drugbank-id": "DB00665",
                        "description": "Nilutamide may increase effectiveness of Gallium Ga 68 gozetotide as a diagnostic agent"
                    },
                    {
                        "drugbank-id": "DB01128",
                        "description": "Bicalutamide may increase effectiveness of Gallium Ga 68 gozetotide as a diagnostic agent"
                    },
                    {
                        "drugbank-id": "DB04839",
                        "description": "Cyproterone acetate may increase effectiveness of Gallium Ga 68 gozetotide as a diagnostic agent"
                    },
                    {
                        "drugbank-id": "DB08899",
                        "description": "Enzalutamide may increase effectiveness of Gallium Ga 68 gozetotide as a diagnostic agent"
                    },
                    {
                        "drugbank-id": "DB11901",
                        "description": "Apalutamide may increase effectiveness of Gallium Ga 68 gozetotide as a diagnostic agent"
                    },
                    {
                        "drugbank-id": "DB12941",
                        "description": "Darolutamide may increase effectiveness of Gallium Ga 68 gozetotide as a diagnostic agent"
                    },
                    {
                        "drugbank-id": "DB13528",
                        "description": "Chlormadinone may increase effectiveness of Gallium Ga 68 gozetotide as a diagnostic agent"
                    },
                    {
                        "drugbank-id": "DB11853",
                        "description": "Relugolix may increase effectiveness of Gallium Ga 68 gozetotide as a diagnostic agent"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}